Company: LICN
Filing Date: 2025-12-02
Form Type: F-3
Source: 0001185185-25-001892
Chunk: 77

Company: Lichen International Ltd
Filing Date: 2025-12-02
Form: F-3
Chunk 77
---
us:

| ● | the                                                                                       
 net tangible book value per share of our equity securities before and after the offering; |

| ● | the                                                                                                                                    
 amount of the increase in such net tangible book value per share attributable to the cash payments made by purchasers in the offering; 
 and                                                                                                                                    |

| ● | the                                                                                                        
 amount of the immediate dilution from the public offering price which will be absorbed by such purchasers. |

<div align='center'>34

USE OF PROCEEDS</div>

We intend to use the net proceeds from the sale of securities we offer as indicated in the applicable prospectus supplement, information incorporated by reference, or free writing prospectus.

<div align='center'>DESCRIPTION OF ORDINARY SHARES</div>

Lichen International Limited is an exempted company incorporated under the Companies Act (Revised) of the Cayman Islands, as amended (the “Cayman Islands Companies Act”). Pursuant to our amended and restated memorandum and amended and restated articles of association, the authorized share capital of our company is US$1,000,000 divided into 100,000,000 Class A Ordinary Shares and 25,000,000 Class B Ordinary Shares, of which 16,216,825 Class A Ordinary Shares and 110,000 Class B Ordinary Shares are issued and outstanding.

The following are summaries of the material provisions of our amended and restated memorandum and articles of association and the Cayman Islands Companies Act, insofar as they relate to the material terms of our ordinary shares. Copies of our amended and restated memorandum and articles of association are filed as exhibits to the most recent annual report on Form 20-F, which is incorporated by reference in this prospectus.

General

As of the date of this prospectus, under our amended and restated memorandum of association, we are authorized to issue 100,000,000 Class A Ordinary Shares with a par value of $0.008 each, and 25,000,000 Class B Ordinary Shares, with a par value of $0.008 each, of which 16,216,825 Class A Ordinary Shares and 110,000 Class B Ordinary Shares are issued and outstanding

Holders of Class A Ordinary Shares and Class B Ordinary Shares will have the same rights except for voting and conversion rights. All of our issued Class A Ordinary Shares and Class B Ordinary Shares are fully paid and non-assessable. Certificates representing the ordinary shares are issued in registered form.

Dividends

The holders of our ordinary shares are entitled